M

Mangoceuticals Inc
NASDAQ:MGRX

Watchlist Manager
Mangoceuticals Inc
NASDAQ:MGRX
Watchlist
Price: 2.65 USD 6% Market Closed
Market Cap: 5.3m USD
Have any thoughts about
Mangoceuticals Inc?
Write Note

Intrinsic Value

MGRX's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one MGRX stock under the Base Case scenario is 0.38 USD. Compared to the current market price of 2.65 USD, Mangoceuticals Inc is Overvalued by 86%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MGRX Intrinsic Value
0.38 USD
Overvaluation 86%
Intrinsic Value
Price
M
Worst Case
Base Case
Best Case

Valuation Backtest
Mangoceuticals Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for MGRX cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about MGRX?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Mangoceuticals Inc

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Mangoceuticals Inc

Provide an overview of the primary business activities
of Mangoceuticals Inc.

What unique competitive advantages
does Mangoceuticals Inc hold over its rivals?

What risks and challenges
does Mangoceuticals Inc face in the near future?

Has there been any significant insider trading activity
in Mangoceuticals Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Mangoceuticals Inc.

Provide P/S
for Mangoceuticals Inc.

Provide P/E
for Mangoceuticals Inc.

Provide P/OCF
for Mangoceuticals Inc.

Provide P/FCFE
for Mangoceuticals Inc.

Provide P/B
for Mangoceuticals Inc.

Provide EV/S
for Mangoceuticals Inc.

Provide EV/GP
for Mangoceuticals Inc.

Provide EV/EBITDA
for Mangoceuticals Inc.

Provide EV/EBIT
for Mangoceuticals Inc.

Provide EV/OCF
for Mangoceuticals Inc.

Provide EV/FCFF
for Mangoceuticals Inc.

Provide EV/IC
for Mangoceuticals Inc.

Compare the intrinsic valuations
of Mangoceuticals Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Mangoceuticals Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Mangoceuticals Inc compared to its peers.

Compare the P/E ratios
of Mangoceuticals Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Mangoceuticals Inc with its peers.

Analyze the financial leverage
of Mangoceuticals Inc compared to its main competitors.

Show all profitability ratios
for Mangoceuticals Inc.

Provide ROE
for Mangoceuticals Inc.

Provide ROA
for Mangoceuticals Inc.

Provide ROIC
for Mangoceuticals Inc.

Provide ROCE
for Mangoceuticals Inc.

Provide Gross Margin
for Mangoceuticals Inc.

Provide Operating Margin
for Mangoceuticals Inc.

Provide Net Margin
for Mangoceuticals Inc.

Provide FCF Margin
for Mangoceuticals Inc.

Show all solvency ratios
for Mangoceuticals Inc.

Provide D/E Ratio
for Mangoceuticals Inc.

Provide D/A Ratio
for Mangoceuticals Inc.

Provide Interest Coverage Ratio
for Mangoceuticals Inc.

Provide Altman Z-Score Ratio
for Mangoceuticals Inc.

Provide Quick Ratio
for Mangoceuticals Inc.

Provide Current Ratio
for Mangoceuticals Inc.

Provide Cash Ratio
for Mangoceuticals Inc.

What is the historical Revenue growth
over the last 5 years for Mangoceuticals Inc?

What is the historical Net Income growth
over the last 5 years for Mangoceuticals Inc?

What is the current Free Cash Flow
of Mangoceuticals Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Mangoceuticals Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Mangoceuticals Inc

Balance Sheet Decomposition
Mangoceuticals Inc

Current Assets 517.6k
Cash & Short-Term Investments 490.2k
Other Current Assets 27.3k
Non-Current Assets 14.7m
PP&E 93.3k
Intangibles 14.6m
Other Non-Current Assets 17k
Current Liabilities 1.4m
Accounts Payable 718.7k
Accrued Liabilities 72.1k
Short-Term Debt 187.5k
Other Current Liabilities 400k
Non-Current Liabilities 29.7k
Other Non-Current Liabilities 29.7k
Efficiency

Earnings Waterfall
Mangoceuticals Inc

Revenue
866.8k USD
Cost of Revenue
-362.4k USD
Gross Profit
504.4k USD
Operating Expenses
-9.4m USD
Operating Income
-8.9m USD
Other Expenses
-222.3k USD
Net Income
-9.1m USD

Free Cash Flow Analysis
Mangoceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MGRX Profitability Score
Profitability Due Diligence

Mangoceuticals Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 1-Year Revenue Growth
Negative Operating Income
Negative Net Income
25/100
Profitability
Score

Mangoceuticals Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

MGRX Solvency Score
Solvency Due Diligence

Mangoceuticals Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Negative Net Debt
Short-Term Solvency
54/100
Solvency
Score

Mangoceuticals Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MGRX Price Targets Summary
Mangoceuticals Inc

There are no price targets for MGRX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MGRX?

Click here to dive deeper.

Dividends

Mangoceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for MGRX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MGRX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Mangoceuticals Inc

Country

United States of America

Industry

Retail

Market Cap

5.1m USD

Dividend Yield

0%

Description

Mangoceuticals, Inc. engages in developing, marketing, and selling men’s wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The firm has developed and is in the process of preparing to commercially market a brand of erectile dysfunction (ED) product under the brand name Mango. The Company’s Mango ED product includes the ingredients, such as Tadalafil (10 milligrams (mg)), Oxytocin (100 International units (IU)) and L-Arginine (50mg), and Tadalafil (20mg), Oxytocin (100IU) and L-Arginine (50mg). The firm connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com for the provision of care via telehealth through its customer portal and provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including its Mango ED product.

Contact

TEXAS
Dallas
4131 N Central Expy, Ste 900
+18336264679
www.mangorx.com

IPO

2023-03-21

Employees

-

Officers

Co-Founder, CEO & Chairman
Mr. Jacob D. Cohen
Chief Financial Officer
Mr. Eugene M. Johnston
Chief Operating Officer
Ms. Amanda Elizabeth Hammer

See Also

Discover More
What is the Intrinsic Value of one MGRX stock?

The intrinsic value of one MGRX stock under the Base Case scenario is 0.38 USD.

Is MGRX stock undervalued or overvalued?

Compared to the current market price of 2.65 USD, Mangoceuticals Inc is Overvalued by 86%.

Back to Top